Horm Metab Res 1986; 18(9): 611-615
DOI: 10.1055/s-2007-1012387
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Effects of Naloxone Infusion on Plasma Levels of LH, FSH, and in Addition TSH and Prolactin in Males, Before and After Oestrogen or Anti-Oestrogen Treatment

L. van Bergeijk, L. J. G. Gooren, H. van Kessel, A. M. Sassen
  • Dept. of Internal Medicine and Laboratory of Obstetrics and Gynaecology, Free University Hospital, Amsterdam, The Netherlands
Further Information

Publication History

1985

1985

Publication Date:
23 April 2008 (online)

Summary

The inhibitory action of endogenous opioids on gonadotrophin release is now well documented. Since LHRH-producing neurons do not possess oestrogen-receptors, it is likely that some other compound mediates the negative feedback action of oestrogens on the gonadotrophin release in the male. To test the hypothesis that endogenous opioids are implicated in this negative feedback action in the human male, the opioid receptor antagonist naloxone (2 mg/h for 4 h) was infused into 7 normogonadotrophic oligozoospermic men before and after 6 weeks of treatment with the oestrogenreceptor antagonist tamoxifen (TAM) (10 mg twice daily) and 6 eugonadal transsexual males before and after 6 weeks of administration of ethinyloestradiol (EE) (10 micrograms three times a day). The effects of naloxone on TSH and prolactin (PRL) release were also studied.

Naloxone administration resulted in a significant release of gonadotrophins, but not of TSH and PRL. Administration of oestrogen and antioestrogen did not significantly affect the response of gonadotrophins to naloxone infusion and no evidence of consistently antagonistic effects of oestrogen and anti-oestrogen on the naloxone-induced gonadotrophin release was obtained. This shows that endogenous opioids are probably not intermediary in the negative feedback control of oestrogens on gonadotrophin release in the human male. Surprisingly, in contrast to the eugonadal transsexual males, FSH levels in the oligozoospermic men did not respond to naloxone administration. As naloxone is thought to exert its action on gonadotrophin release via a disinhibition of endogenous LHRH release, this finding is unexpected. Exogenous LHRH administration leads to a normal response of FSH in normogonadotrophic oligozoospermic men. No plausible explanation for this finding can presently be offered.

    >